INDV

Indivior Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality5/10
  • Growth↑ 9/10
  • Value↓ 4/10
Indivior Pharmaceuticals sales and earnings growth
INDV Growth
Great
  • Revenue Y/Y↑ 9.89%
  • EPS Y/Y↑ 10150.00%
  • FCF Y/Y↓ -265.52%
Indivior Pharmaceuticals gross and profit margin trends
INDV Profitability
Good
  • Gross margin ↑ 81.30%
  • EPS margin↑ 19.40%
  • ROIC 5Y↑ 0.00%
Indivior Pharmaceuticals net debt vs free cash flow
INDV Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 1.7
  • Interest coverage↑ 8.4

Indivior Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks